Psychiatr. praxi. 2011;12(1):13-18 [Neurol. praxi. 2010;11(3):172-176]

Alzheimer disease and the engagement of informal carers in a fight for the quality of life

MUDr.Kateřina Sheardová
1. neurologická klinika FN u sv. Anny a LF MU, Brno

A successful therapy of dementia should positively influence cognitive functions as well as the quality of life and behavioral and psychological

symptoms. This goal can be achieved by combination of pharmacological and non-pharmacological approaches. Diseases

manifesting with dementia are a heavy burden not only for the patients but also for caregivers caring for their relatives at home. The

article reviews current therapeutic approaches to dementia with the focus on non-pharmacological interventions that informal carers

might try or access in the home background.

Keywords: dementia, therapy, non-pharmacological approaches, BPSD, quality of life

Published: January 7, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sheardová K. Alzheimer disease and the engagement of informal carers in a fight for the quality of life. Psychiatr. praxi. 2011;12(1):13-18.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bartus RT, Dean RL 3rd, Beer B, and Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction Science 1982; Vol 217, Issue 4558, 408-414. Go to original source... Go to PubMed...
    2. Black S, Roman GC, Geldmacher DS, et al. The Donepezil 307 Vascular Dementia Study Group. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 2003; 34: 2323-2330. Go to original source... Go to PubMed...
    3. Brodaty H, Green Al, Koschera A. Meta-Analysis of Psychosocial Interventions for Caregivers of People with Dementia, Journal of American Geriatric Society 2000; 51: 1-8.
    4. Burns A, Lliffe S. Dementia. Br Med J 2009; 338: 405-409. Go to original source... Go to PubMed...
    5. Cummings JL, Back C. The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. Am J Geriatr Psychiatry. 1998; 6(2 Suppl. 1): S64-78. Go to original source... Go to PubMed...
    6. Emre M, Aarsland D, Albanese A, et al. Rivastigmine for dementia associated with Parkinson's disease. New England Journal of Medicine 2004; 351: 2509-2518. Go to original source... Go to PubMed...
    7. Geda YE, Roberts RO, Knopman DS, et al. Physical exercise, aging, and mild cognitive impairment: a population-based study. Arch Neurol. 2010; 67(1): 80-86. Go to original source... Go to PubMed...
    8. Graff MJ, Adang EM, Vernooij-Dassen MJ, et al. Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. BMJ 2008; 19, 336 (7636): 134-138. Go to original source... Go to PubMed...
    9. Gräsel E, Wiltfang J, Kornhuber. Non-drug therapies for dementia: an overview of the current situation with regard to proof of effectiveness. J. Dement Geriatr Cogn Disord. 2003; 15(3): 115-125. Go to original source... Go to PubMed...
    10. Holmerová I, Janečková H, Vaňková H, Veleta P. Nefarmakologické přístupy v terapii Alzheimerovy demence a praktické aspekty péče o postižené. Psychiat pro Praxi 2005; 6(4): 175-178.
    11. Hulme C, Wright J, Crocekr T, Oluboyede Y and House A. Non-pharmacological approaches for dementia that informal carers might try or access: a systemic review. Int J Geriatr Psychiatry Nov 2009 Epub ahead of print. Go to original source... Go to PubMed...
    12. Mazza M, Capuano A, Bria P, Mazza S. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. European Journal of Neurology 2006; 13: 981-985. Go to original source... Go to PubMed...
    13. Raskind MA, Peskind ER, Wessel T, Yuan W. Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology 2000; 54: 2261-2268. Go to original source... Go to PubMed...
    14. Rayner AV, O´Brien JG, Schoenbachler B. 2006. Behaviour Disorders of Dementia: Recognition and Treatment. American Family Physican 73(4): 647-652.
    15. Sheardová K, Hort J, Rusina R, et al. Doporučené postupy pro léčbu Alzheimerovy nemoci a dalších onemocnění spojených s demencí. Česk slov neurol N. 2007; 70/103(5): 253-258.
    16. Winblad B, Grossberg G, Frölich L, et al. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease. Neurology 2007; 24, 69(4 Suppl. 1): S14-22. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.